Funding Received
$48.7 Million in 8 Rounds from 6 Investors
Most Recent Funding
$2.2 Million Debt Financing on January 22, 2014
Headquarters:
San Carlos, CA
Description:
Cellerant Therapeutics is a biotechnology company offering products for the regulation of the hematopoietic system.
Categories:
Biotechnology
Website:
http://www.cellerant.com

Detailed Description

Update

Cellerant Therapeutics is a biotechnology company with a portfolio of products based on the regulation of the hematopoietic (blood-forming) system. The company focuses on curative therapies for seriously ill patients.

Cellerant is developing a novel, cell-based medicine (Myeloid Progenitors / CLT-008) as a treatment for chemotherapy- and radiation-induced neutropenia as well as for Acute Radiation Syndrome. And we are applying our expertise in hematopoietic ontogeny to identify novel drug targets and therapeutic antibodies aimed at cancer stem cells.

Current Team (8)

Update

Funding Rounds (8) - $2.2M

Update

Board Members and Advisors (4)

Update

Investors (6)

Update

Offices/Locations (1)

Update
  • HQ

    1561 Industrial Road

    San Carlos, CA 94070

    USA